Acasti’s main mission and top priority is to research and develop innovative and proprietary pharmaceutical products designed to better manage cardiometabolic disorders.
Acasti Pharma is advancing a potentially best-in-class omega-3 therapeutic for the treatment of hypertriglyceridemia.
Sourced from krill, CaPre® is designed to deliver a trifecta of cardiometabolic health benefits to patients in need.
Our passionate executives and scientists bring decades of experience developing and commercializing novel therapeutics.
